Table 6 Characteristics of papers reporting promising results of TCM
Table 4. The Revised Bethesda Guidelines for Testing
Table 4 Observed MFSI-SF scores
Table 3: Amsterdam criteria II
Table 2: Studies on SNAI1 performed with immunohistochemistry on
Table 2: Results of literature review
Table 2: Amsterdam criteria I
Table 2.3. Rates of detection of type
Table 2. Results for measurement of plasma fibronectin using
Table 1. Percentage of Resected NSCLC Stage II and IIIA Patients T
Table 1 shows the characteristics of the studies included
Table 1 Contraindications for use of rhBMP
Table 1 - LWW.com
Table 1 - International Journal of Cancer Therapy and Oncology
Table 1
Table 1
TAA loaded DCs did not consistently induce clinically relevant
T4 - Royal College of Surgeons in Ireland
T32_GMaP_Listserv_Notice
T2N0 Esophageal Cancer: Does it Exist? Should we give
